Jan 10, 2022 / 12:30PM GMT
Calvin Alexander Sternick - JPMorgan Chase & Co, Research Division - Analyst
Good morning, and thank you for joining us here at the 40th Annual JPMorgan Healthcare Conference. I'm Cal Sternick and I'll be moderating today's discussion. I'm pleased to have with me here this morning from Centene, Sarah London, who is Vice Chairman and President of Healthcare Enterprises and Executive Vice President of Advanced Technology; and Executive Vice President and Chief Financial Officer, Drew Asher; as well as SVP and Head of IR, Jen Gilligan. So thank you all for joining us.
For those listening on the conference webcast, there is an ask-a-question feature if you'd like to submit a question to the queue. Before we get started, I'm going to turn it over to Centene for some introductory remarks. Sarah, Drew, the floor is yours.
Sarah M. London - Centene Corporation - President of Health Care Enterprises & Executive VP of Advanced Technology & Vice Chairman
Great. Thank you, Cal. Good morning, everyone. I'm glad to kick off the conference, sad that we can
Centene Corp at JPMorgan Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot